Evogene Ltd.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Evogene Ltd. now
Current reporting with the operating signal separated from the noise.
EVGN|Evogene Ltd|Price:0.471|Chg%:-0.016
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene Ltd (EVGN) Risk Assessment: Volatility, Financial Risk & Investment Risk
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene Ltd (EVGN) Struggles Near Support as Selling Pressure Persists - Leveraged ETF Flow
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene Ltd (EVGN) Struggles Near Support as Selling Pressure Persists - Wide Range Bar
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene; ELEO Inc.: Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and ...
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene Ltd. and ELEO Inc. Announce Collaboration to Develop Next-Generation Oral Small-Molecule PCSK9 Pathway Inhibitors for Hyperlipidemia and Cardiovascular Diseases
The story matters when it changes Evogene Ltd.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Evogene Ltd. (EVGN) Q4 2024 Earnings Call Transcript
Investors are testing whether Evogene Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Evogene Ltd. (NASDAQ:EVGN) Q3 2023 Earnings Call Transcript
Investors are testing whether Evogene Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Evogene Ltd. (NASDAQ:EVGN) Q2 2023 Earnings Call Transcript
Investors are testing whether Evogene Ltd.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest EVGN filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Evogene Ltd., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →